BiotechTube
Home/Radella Pharmaceuticals/Michael Zemel, PhD
MZ

Michael Zemel, PhD

Chief Scientific Officer

Radella Pharmaceuticals

Therapeutic Areas

Cardiometabolic DiseaseDiabetesObesityAtherosclerosisDementiaFatty Liver Disease

Radella Pharmaceuticals Pipeline

DrugIndicationPhase
Undisclosed Lead ProgramDiabetes / ObesityPre-clinical

Leadership Team at Radella Pharmaceuticals

DC
Daniel Cohen
Founder, Chairman & CEO
AT
Amir Tirosh, MD, PhD
Chief Medical Officer
PL
Phillip Lehman
Chief Operating Officer, Head of BD
View full Radella Pharmaceuticals profile